Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
25/06/2026 07:10
BRIEF-Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority June 25 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd GLAX.NS:
GLAXOSMITHKLINE PHARMACEUTICALS - RECEIVES DEMAND NOTICE FROM NATIONAL PHARMACEUTICAL PRICING AUTHORITY
GLAXOSMITHKLINE PHARMACEUTICALS - TOTAL DEMAND OF 35.4 MILLION RUPEES
Source text: ID:nBSE3Kc6r3
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees